share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  08/20 16:28

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 08/20/2024, as per the latest filing. These shares, valued at approximately $81,532.92, were originally acquired as founder's shares on 09/01/2016 as compensation from the issuer. This planned sale follows a series of transactions over the past three months, where Borgeson sold a total of 68,682 Class A shares, generating gross proceeds of $569,369.77. The upcoming sale continues Borgeson's pattern of share disposals, which have been regularly occurring since May 2024.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 08/20/2024, as per the latest filing. These shares, valued at approximately $81,532.92, were originally acquired as founder's shares on 09/01/2016 as compensation from the issuer. This planned sale follows a series of transactions over the past three months, where Borgeson sold a total of 68,682 Class A shares, generating gross proceeds of $569,369.77. The upcoming sale continues Borgeson's pattern of share disposals, which have been regularly occurring since May 2024.
Recursion Pharmaceuticals,Inc.董事Blake Borgeson計劃於2024年08月20日賣出11,447股A類股票,根據最新提交的文件。這些股票價值約爲$81,532.92,最初是作爲獎金於2016年09月01日從發行人處獲得的創始股份。這次計劃中的出售是Borgeson在過去三個月中一系列交易的延續,他出售了總計68,682股A類股票,獲得了569,369.77美元的總收入。即將到來的沽出繼續了Borgeson的股票處理模式,這種模式自2024年5月以來一直在定期發生。
Recursion Pharmaceuticals,Inc.董事Blake Borgeson計劃於2024年08月20日賣出11,447股A類股票,根據最新提交的文件。這些股票價值約爲$81,532.92,最初是作爲獎金於2016年09月01日從發行人處獲得的創始股份。這次計劃中的出售是Borgeson在過去三個月中一系列交易的延續,他出售了總計68,682股A類股票,獲得了569,369.77美元的總收入。即將到來的沽出繼續了Borgeson的股票處理模式,這種模式自2024年5月以來一直在定期發生。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息